Cardiovascular risk assessment for osteoporosis patients considering Romosozumab.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 39454743.
- Also identified by DOI 10.1016/j.bone.2024.117305.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cardiovascular risk scoaring tools are suitable for but not interchangable within the osteoporosis clinic.
Medical subject headings
- Antibodies, Monoclonal
- Cardiovascular Diseases
- Osteoporosis